Protocol No
NEURO-NOVARTIS-LOU064
Phase
III
Summary
This study will compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis.
Description
Remibrutinib vs Teriflunomide in Relapsing MS
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
ClinicalTrials.gov